HAB Pharmaceuticals Targets ₹3,000 Crore Revenue by 2030 Following Strategic Merger
Mumbai : HAB Pharmaceuticals & Research Limited has announced an ambitious growth roadmap following the successful completion of its strategic merger with Signature Phytochemical!-->…